Port Washington, NY 12/19/11—Filtration, separation and purification solutions provider Pall has signed a definitive agreement to acquire ForteBio for an undisclosed amount. ForteBio is a developer of label-free protein analysis instruments, including the Octel products based on BioLayer Interferometry technology. “BioPharmaceuticals continues to be the engine of our Life Sciences business and an important long-term […]
On December 23, President Obama signed into law an omnibus bill that will support the government for the rest of fiscal 2012. The final appropriations bill included funding for the NIH, the Department of Energy (DOE), the Centers for Disease Control and Prevention (CDC), the FDA and the EPA. Like the fiscal 2012 budgets for […]
Global equity markets slumped in 2011 with the exception of the US. The European sovereign debt crisis and natural disasters led the majority of Asia Pacific and European stock indexes down by double digits. US stock markets experienced similar volatility but ended the year with mixed results. Positive earnings reports lifted US equity prices in […]
Fluorescence correlation spectroscopy (FCS) is a relatively new subsegment of the fluorescence spectroscopy market designed for advanced research. FCS can provide very specific physiochemical information that is most useful in biology and related sectors. Technical advancements in recent decades have allowed the technique to be developed as a commercial instrument technique that is still in […]
Soon after releasing its “Autumn Statement” in November, the UK unveiled its “Strategy for the UK Life Sciences.” The reports detail the UK’s plans for furthering economic growth and encouraging foreign investment. The “Strategy for the UK Life Sciences” outlines plans to benefit the industry. The government has designated £310 million ($500 million = £0.62 […]
ASD is a company confident in its future. The combination of the firm’s portable instruments, application experience and two decades in natural resource management, as well as high natural resource commodity prices, has boosted its management team’s confidence that its compound annual growth rate will be above 25% over the next five years—perhaps higher, if […]
Company Announcements In September, the FDA, University of Maryland, their Joint Institute for Food Safety and Applied Nutrition (JIFSAN) and Waters opened the International Food Safety Training Laboratory to provide hands-on lab training on detection methods and classroom methods on regulatory standards. Operated by the JIFSAN, the lab will be able to teach 200 professionals […]
Company Announcements Certara announced in October that it will be the exclusive provider of Chemotargets’ software for predicting the off-target pharmacology of small molecules through the creation of customized ligand-based target models. In October, Accelrys agreed to market and sell SCYNEXIS’s Hit Explorer Operating System, a software-as-a-service workspace that supports real-time data sharing across multiple […]
Company Announcements In September, Verinata Health announced a three-year supply agreement to purchase Illumina’s HiSeq 2000 instruments and consumables for use in the commercialization of noninvasive prenatal testing for the detection of multiple aneuploidies. The companies will also collaborate on gaining regulatory approval for the testing service. In October, Illumina entered into a collaborative research […]
Company Announcements Ocean Optics named Kevin Chittim president in September, replacing Robert Randelman, who was promoted to divisional chief executive for parent company Halma. Mr. Chittim previously served as CEO of Labsphere, another Halma company. In October, Avacta extended its distribution agreement with Pall to include Southeast Asia. Product Introductions Picarro introduced the field-portable L2130-i […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
